Table 3 The diagnostic tests before regression
From: Board of directors and earnings manipulation: evidence from regulatory change
Variance inflation factor | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Variables | ROA | BEXP | ACEXP | LOSS(D) | BIND | FSIZE | ACIND | SALES | BIG4 | INV |
VIF | 2.65 | 2.05 | 1.92 | 1.87 | 1.73 | 1.65 | 1.64 | 1.63 | 1.56 | 1.53 |
1/VIF | 0.38 | 0.49 | 0.52 | 0.54 | 0.58 | 0.61 | 0.61 | 0.61 | 0.64 | 0.65 |
Variables | LEVE | TANG | FD | BSIZE | BF | BMEET | FAGE | CEOD | CFO | Â |
VIF | 1.49 | 1.34 | 1.26 | 1.23 | 1.18 | 1.18 | 1.09 | 1.03 | 1.01 | Â |
1/VIF | 0.67 | 0.75 | 0.79 | 0.81 | 0.85 | 0.85 | 0.92 | 0.97 | 0.99 | Â |
Breusch–Pagan/Cook–Weisberg test for heteroscedasticity |  |
|---|---|
Ho: Constant variance Variables: fitted values of MCDA χ2 (1) = 5.26 χ2 > chi2 = 0.0219 |  |
Wooldridge test for autocorrelation | Â |
|---|---|
H0: no first-order autocorrelation F ( 1, 197) = 0.279 F-Statistics = 0.5980 |  |